(Q34264517)

1 August 2017

1 reference

title

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? (English)

1 reference

1 August 2017

0 references

1 reference

3

Andrew J Lees

1 reference

1 August 2017

2

Andrew H Evans

1 reference

1 August 2017

Andrew D. Lawrence

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14505581

13 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14505581

13 March 2024

publication date

1 October 2003

1 reference

full work available at URL

1 August 2017

https://api.elsevier.com/content/article/PII:S1474442203005295?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

https://api.elsevier.com/content/article/PII:S1474442203005295?httpAccept=text/plain

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

13 March 2024

1 reference

1 August 2017

2

1 reference

1 August 2017

10

1 reference

1 August 2017

595-604

1 reference

Neuropathology of Parkinson's disease

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Psychiatric Side Effects of Levodopa in Man

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Psychiatric aspects in Parkinsonism treated with L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Clinical effects of amphetamine and L-DOPA on sexuality and aggression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Dopa dose-dependent sexual deviation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Levodopa dependence: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

1 reference

7 January 2021

Levodopa addiction. A case study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Hypersexuality with Antiparkinsonian Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

L-dopa abuse in a patient with former alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Is there addiction to levodopa in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Pathologic gambling in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Behavioural disorders, Parkinson's disease and subthalamic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Selegiline and manic behavior in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Stereotyped activities produced by amphetamine in several animal species and man

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

1 reference

7 January 2021

Serial cognitive profiles in levodopa-induced hypersexuality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Apomorphine-induced penile erections in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Fluctuating penile erection related with levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

A 'crash' course on psychostimulant withdrawal as a model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the antiparkinsonian effects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Apomorphine tolerance in Parkinson's disease: lack of a dose effect.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Mood changes and "on-off" phenomena in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

1 reference

7 January 2021

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Conditioned place preference induced by a combination of L-dopa and a COMT inhibitor, entacapone, in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Paradoxical reinforcing properties of apomorphine: effects of nucleus accumbens and area postrema lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Mood response to levodopa infusion in early Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Individual differences in mood reactions to d-amphetamine: a test of three personality factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The role of brain emotional systems in addictions: a neuro-evolutionary perspective and new 'self-report' animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Comparative expression of hedonic impact: affective reactions to taste by human infants and other primates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

An opponent-process theory of motivation. II. Cigarette addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Drug addiction, dysregulation of reward, and allostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Reduced reward processing in the brains of Parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The role of withdrawal in heroin addiction: enhances reward or promotes avoidance?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The neuropsychological basis of addictive behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Attentional orienting towards smoking-related stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Psychomotor stimulant addiction: a neural systems perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Dopamine responses comply with basic assumptions of formal learning theory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Addiction, dopamine, and the molecular mechanisms of memory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Washing, drying, and anointing in adult humans (Homo sapiens): Commonalities with grooming sequences in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The interaction of cognitive and stimulus-response processes in the control of behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Brain reward circuitry: insights from unsensed incentives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Effects of medial prefrontal or anterior cingulate cortex lesions on responding for cocaine under fixed-ratio and second-order schedules of reinforcement in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Forced collectionism after orbitofrontal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Chronic intermittent amphetamine pretreatment enhances future appetitive behavior for drug- and natural-reward: interaction with environmental variables

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Drug addiction as dopamine-dependent associative learning disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Continuous dopamine-receptor stimulation in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Worsening of levodopa-induced dyskinesias by motor and mental tasks

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

"Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Nucleus Accumbens Dopamine and the Regulation of Effort in Food-Seeking Behavior: Implications for Studies of Natural Motivation, Psychiatry, and Drug Abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Animal models of neurological deficits: how relevant is the rat?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Evidence for striatal dopamine release during a video game.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Cultural objects modulate reward circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

'Behavioral' addictions: do they exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Selective disruption of the recognition of facial expressions of anger

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Discrete coding of reward probability and uncertainty by dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Dopamine: generalization and bonuses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The neuroscience of natural rewards: relevance to addictive drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Cocaine sensitization and reward are under the influence of circadian genes and rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Interaction between glucocorticoid hormones, stress and psychostimulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Pavlovian conditioning of L-dopa induced movement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Incentive sensitization by previous amphetamine exposure: increased cue-triggered "wanting" for sucrose reward.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Pathological gambling associated with dopamine agonist therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Treatment results: Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900529-5

7 January 2021

The spectrum of levodopa-induced dyskinesias

8

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

Levodopa Dependence and Hypersexuality in an Older Parkinson's Disease Patient

13 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs

13 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

Sexual function and affect in parkinsonian men treated with L-dopa

13 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease

13 March 2024

130

1 reference

https://api.crossref.org/works/10.1016/S1474-4422(03)00529-5

13 March 2024

Identifiers

1 reference

1 August 2017

1 reference